| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-11 14:08:50 UTC |
|---|
| Updated at | 2022-09-11 14:08:51 UTC |
|---|
| NP-MRD ID | NP0315489 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium |
|---|
| Description | Ceftazidime, also known as CAZ or ceptaz, belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof. Ceftazidime is a drug which is used for the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: Lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis). Ceftazidime is a strong basic compound (based on its pKa). 1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium is found in Apis cerana. 1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium was first documented in 1992 (PMID: 1384868). A third-generation cephalosporin antibiotic bearing pyridinium-1-ylmethyl and {imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton (PMID: 11252323) (PMID: 11284241) (PMID: 11591698) (PMID: 11605815) (PMID: 11815759) (PMID: 12048030). |
|---|
| Structure | [O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1 InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ChEBI | | CAZ | ChEBI | | Ceftazidima | ChEBI | | Ceftazidime anhydrous | ChEBI | | Ceftazidimum | ChEBI | | Ceptaz | Kegg | | Fortaz | Kegg | | (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Generator | | Pentahydrate, ceftazidime | HMDB | | Fortum | HMDB | | Anhydrous, ceftazidime | HMDB | | Ceftazidime pentahydrate | HMDB | | Tazidime | HMDB |
|
|---|
| Chemical Formula | C22H22N6O7S2 |
|---|
| Average Mass | 546.5760 Da |
|---|
| Monoisotopic Mass | 546.09914 Da |
|---|
| IUPAC Name | 1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium |
|---|
| Traditional Name | ceftazidime |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1 |
|---|
| InChI Key | ORFOPKXBNMVMKC-DWVKKRMSSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Lactams |
|---|
| Sub Class | Beta lactams |
|---|
| Direct Parent | Cephalosporins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cephalosporin
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- 2,4-disubstituted 1,3-thiazole
- Meta-thiazine
- Dicarboxylic acid or derivatives
- 1,3-thiazol-2-amine
- Pyridine
- Pyridinium
- Azole
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Thiazole
- Amino acid or derivatives
- Azetidine
- Carboxamide group
- Carboxylic acid salt
- Amino acid
- Secondary carboxylic acid amide
- Thioether
- Hemithioaminal
- Dialkylthioether
- Azacycle
- Carboxylic acid derivative
- Carboxylic acid
- Primary amine
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Organic salt
- Organonitrogen compound
- Organic zwitterion
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Shimizu T, Souma S, Nagakura N, Masuzawa T, Iwamoto Y, Yanagihara Y: Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity. Int Arch Allergy Immunol. 1992;98(4):392-7. doi: 10.1159/000236216. [PubMed:1384868 ]
- Marumo K, Takeda A, Nakamura Y, Nakaya K: Detection of OXA-4 beta-lactamase in Pseudomonas aeruginosa isolates by genetic methods. J Antimicrob Chemother. 1999 Feb;43(2):187-93. doi: 10.1093/jac/43.2.187. [PubMed:11252323 ]
- Orrett FA, Shurland SM: Neonatal sepsis and mortality in a regional hospital in Trinidad: aetiology and risk factors. Ann Trop Paediatr. 2001 Mar;21(1):20-5. doi: 10.1080/02724930020028867. [PubMed:11284241 ]
- Zhang Z, Yu Y, Musser JM, Palzkill T: Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase. J Biol Chem. 2001 Dec 7;276(49):46568-74. doi: 10.1074/jbc.M102757200. Epub 2001 Oct 8. [PubMed:11591698 ]
- Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW: Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect. 2001 Sep;34(3):215-9. [PubMed:11605815 ]
- Bruckner LB, Korones DN, Karnauchow T, Hardy DJ, Gigliotti F: High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr. 2002 Jan;140(1):20-6. doi: 10.1067/mpd.2002.118886. [PubMed:11815759 ]
- Di Martino P, Gagniere H, Berry H, Bret L: Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients. Microbes Infect. 2002 May;4(6):613-20. doi: 10.1016/s1286-4579(02)01579-4. [PubMed:12048030 ]
- Astal Z, El-Manama A, Sharif FA: Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip. J Chemother. 2002 Jun;14(3):259-64. doi: 10.1179/joc.2002.14.3.259. [PubMed:12120880 ]
- Barekzi NA, Felts AG, Poelstra KA, Slunt JB, Grainger DW: Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections. Pharm Res. 2002 Dec;19(12):1801-7. doi: 10.1023/a:1021481122011. [PubMed:12523657 ]
- White NJ: Melioidosis. Lancet. 2003 May 17;361(9370):1715-22. doi: 10.1016/s0140-6736(03)13374-0. [PubMed:12767750 ]
- Guerrero C, Cesteros R, Miranda A, Menasalvas A, Blazquez R, Segovia M: [Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Murcia, Spain]. Rev Esp Quimioter. 2003 Dec;16(4):444-9. [PubMed:14961139 ]
- Bret L, Di Martino P: Effect of ceftazidime, amikacin and ciprofloxacin on biofilm formation by some enterobacterial clinical isolates. Chemotherapy. 2004 Nov;50(5):255-9. doi: 10.1159/000081947. Epub 2004 Nov 3. [PubMed:15528892 ]
- Araki H, Ogake N, Tsuneda R, Minami S, Watanabe Y, Tamai I, Tsuji A: Muscle distribution of antimicrobial agents after a single intravenous administration to rats. Drug Metab Pharmacokinet. 2002;17(3):237-44. doi: 10.2133/dmpk.17.237. [PubMed:15618675 ]
- Perez-Capilla T, Baquero MR, Gomez-Gomez JM, Ionel A, Martin S, Blazquez J: SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol. 2005 Feb;187(4):1515-8. doi: 10.1128/JB.187.4.1515-1518.2005. [PubMed:15687217 ]
- de Jong CE, Jonsson N, Field H, Smith C, Crichton EG, Phillips N, Johnston SD: Collection, seminal characteristics and chilled storage of spermatozoa from three species of free-range flying fox (Pteropus spp.). Theriogenology. 2005 Sep 15;64(5):1072-89. doi: 10.1016/j.theriogenology.2005.02.016. [PubMed:15913752 ]
- LOTUS database [Link]
|
|---|